These innovative medications , Tirzepatide , represent a significant advancement in managing metabolic dysfunction and possibly related disorders. They are categorized as GLP-1 pathway agonists , meaning they function to emulate the endogenous GLP-1 substance , enhancing glucose secretion and lowering appetite . While Retatrutide each one works … Read More